Discovera
Discovera enables faster drug discovery through computational design. It uses AI-driven platforms, machine learning, structural biology, and cheminformatics to identify and validate therapeutic targets, optimize hit-to-lead, and predict clinical outcomes with in vitro efficacy testing. The work spans small molecules and diverse therapeutic areas, supported by proprietary tech that integrates data-rich modeling across the discovery pipeline. The company operates as a B2B partner offering streamlined, high-value collaborations and data-driven insights for researchers and pharma. Its platform and expertise position it to accelerate development across research stages and modalities.
Discovera
Discovera enables faster drug discovery through computational design. It uses AI-driven platforms, machine learning, structural biology, and cheminformatics to identify and validate therapeutic targets, optimize hit-to-lead, and predict clinical outcomes with in vitro efficacy testing. The work spans small molecules and diverse therapeutic areas, supported by proprietary tech that integrates data-rich modeling across the discovery pipeline. The company operates as a B2B partner offering streamlined, high-value collaborations and data-driven insights for researchers and pharma. Its platform and expertise position it to accelerate development across research stages and modalities.